When Kay Wesley moved from the world of dot com to work as global digital director at AstraZeneca, she realised that pharma was transforming for digital at a rather different pace.
If a particularly important and digitally well-connected HCP tweeted about your new data today, and assuming 50% of their HCP followers retweeted that, and assuming 50% of those followers’
A large number of US consumers are wary of content from social media, presenting opportunities for pharma to become trusted resources for health information, says Richard Meyer.
Bavarian Nordic is preparing to file for regulatory approval of a vaccine against chikungunya virus after its CHIKV VLP candidate showed protective efficacy in a second ph
To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho